Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Molecular Biosystems Acquisition Builds Alliance's Cardiac Imaging Portfolio

This article was originally published in The Gray Sheet

Executive Summary

Alliance Pharmaceutical's acquisition of Molecular Biosystems, Inc. for $10.2 mil. in stock will expand its existing ultrasound cardiac imaging agent portfolio to include royalties for Optison.
Advertisement

Related Content

Photogen Buys Alliance’s Imagent To Build Cardiovascular Imaging Franchise
Photogen Buys Alliance’s Imagent To Build Cardiovascular Imaging Franchise
Alliance Touts Imagent Synthetic Heart Imaging Agent As Easier To Store
Alliance Touts Imagent Synthetic Heart Imaging Agent As Easier To Store
Advertisement
UsernamePublicRestriction

Register

MT013994

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel